Journal of Cancer

EARLY CHANGES IN ALBUMIN PREDICT BENEFIT FROM IMMUNE CHECKPOINT INHIBITORS IN ADVANCED NON-SMALL CELL LUNG CANCER. Yizhen Guo. 1, Lai Wei. 2, Mitch A. Phelps. 1, and … ................
................